Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream

  1. Home

  • Saturday, Nov 16th
    7:30 AM – 8:30 AM Eastern Time
    MTP05A: Meet the Professor: Vasculitis
    Location: Room 148
    Seminar Presenter: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
     CME 1 hours
  • Saturday, Nov 16th
    9:00 AM – 10:00 AM Eastern Time
    16S07: The JCR-ACR Scientific Session: At the Heart of the Inflamed Vessel: New Insights into Cardiovascular Disease and Vasculitis
    Location: Room 145AB
    Moderator: Theresa Lu, MD, PhD – Hospital for Special Surgery
    Moderator: Yukinori Okada, MD;PhD – The University of Tokyo / Osaka University / RIKEN
    Vasculitis
     CME 1 hours
  • Saturday, Nov 16th
    9:00 AM – 9:20 AM Eastern Time
    Novel Aspects of Complement Functions in Cardiovascular Disease
    Location: Room 145AB
    Speaker: Claudia Kemper, PhD – National Institutes of Health
    Vasculitis
  • Saturday, Nov 16th
    9:20 AM – 9:40 AM Eastern Time
    Single Cell Multi-Omics Elucidates Distinct Sub-Phenotypes of Microscopic Polyangiitis
    Location: Room 145AB
    Speaker: Masayuki Nishide, MD, PhD – Osaka University
    Vasculitis
  • Saturday, Nov 16th
    9:40 AM – 10:00 AM Eastern Time
    Mechanisms of Vascular Damage in Autoimmunity
    Location: Room 145AB
    Speaker: Mariana Kaplan, MD (she/her/hers) – NIAMS/NIH
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    Vasculitis – ANCA-Associated Poster II
    Vasculitis
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    Vasculitis – Non-ANCA-Associated & Related Disorders Poster I
    Vasculitis
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0714: Therapeutic Dilemmas in Patients with ANCA-associated Vasculitis: Diffuse Alveolar Hemorrhage, Venous Thromboembolism and Anticoagulation
    Abstract Poster Presenter: Elif Ediboglu, M.D. – Mayo Clinic
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0715: Diffuse Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Revisited
    Abstract Poster Presenter: Elif Ediboglu, M.D. – Mayo Clinic
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0716: Outcomes of COVID-19 in Patients with ANCA-Associated Vasculitis (AAV)
    Abstract Poster Presenter: Husam El Sharu, MD – East Carolina University
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0717: Associations Between Calendar Time and Age at Diagnosis with Mortality in a National Cohort of Veterans with ANCA-Associated Vasculitis from 2001-2020
    Abstract Poster Presenter: Jennifer Hanberg, MD – Brigham and Women's Hospital
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0718: Incidence and Patient Profile Changes in ANCA-Associated Vasculitis Following the SARS-CoV-2 Pandemic
    Abstract Poster Presenter: Laura Ramos Ortiz de Zarate, MD – Hospital Universitario Puerta de Hierro Majadahonda
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0719: Risk of Vertebral Fracture in Individuals with Granulomatosis with Polyangiitis and End-Stage Renal Disease
    Abstract Poster Presenter: Joanna El Hajj, MD – Augusta University
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0720: Impact of Systemic Vasculitides on Sexual Function: An Overlooked Aspect of Patient Care
    Abstract Poster Presenter: Javier Merayo-Chalico, MD – Reumátika, Centro de Vanguardia en Reumatología
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0721: Does Serial ANCA Testing Help Predict the Risk of Relapse in Granulomatosis with Polyangiitis? A Single-center Cohort Study
    Abstract Poster Presenter: Xavier Puéchal, MD,PhD – National Referral Center for Rare Systemic Autoimmune Diseases
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0722: Factors Associated with Relapses and Performance of the French Vasculitis Study Group Relapse Score in a Cohort of Mexican Patients with ANCA-Associated Vasculitis
    Abstract Poster Presenter: Andrea Hinojosa-Azaola, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0723: Sociodemographic Factors Associated with Clinic Non-attendance and Unscheduled Emergency Care Episodes in ANCA-associated Vasculitis
    Abstract Poster Presenter: Rosemary Hollick, BSc, MBChB, PhD, FRCP – University of Aberdeen
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0724: Incidence of ANCA-Associated Vasculitis in a Northern Spanish Health Region Between 2000-2023: A Populatio-based Study
    Abstract Poster Presenter: Fabricio Benavides, MD (he/him/his) – Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0725: Serum Glial Fibrillary Acidic Protein Could Assess Cross-sectional Vasculitis Activity by Reflecting Renal Involvement in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
    Abstract Poster Presenter: Lucy Eunju Lee, n/a – Yonsei University
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0726: Management of ANCA Vasculitis-Associated Orbital Inflammatory Disease: A Systematic Literature Review
    Abstract Poster Presenter: Emma Neary, MD – McGill University
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0727: Prospective Cellular Biomarkers in ANCA Associated Vasculitis: A Pilot Study
    Abstract Poster Presenter: Jakub Videman, MD – University Hospital Olomouc
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0728: Glomerular Proteomic Signature in ANCA-associated Glomerulonephritis
    Abstract Poster Presenter: Ivana Stojkic, MD – Nationwide
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0729: Factors Associated with Pauci-immune Glomerulonephritis in Patients Undergoing Renal Biopsy with Positive ANCA Results
    Abstract Poster Presenter: Jiyun Lee, -None- – University of Ulsan College of Medicine
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0730: Assessment of the Quality of Life in a Single-center Cohort of Patients with ANCA-Associated Vasculitis on Targeted Therapy: Characterization of Global, Disease and Organ-specific Parameters Using Patient Reported Outcomes
    Abstract Poster Presenter: Michele Moretti, MD – University of Pisa
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0731: Differentiating Primary Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis from Secondary Forms
    Abstract Poster Presenter: Adil Vural, MD – Cleveland Clinic
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0732: Antineutrophil Cytoplasmic Antibodies and Associated Vasculitis According to Clinical Phenotypes: A Single-Center Retrospective Cohort Study
    Abstract Poster Presenter: Mireia Lucía Sanmartín Martínez, MD (she/her/hers) – Hospital General Universitario de Valencia
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0733: Inpatient Outcomes in ANCA-Associated Vasculitis: An In-Depth Cross-Sectional Analysis Using NIS Data (2016-2020)
    Abstract Poster Presenter: Sai Shanmukha Sreeram Pannala, MD (he/him/his) – Northwell health/Staten Island university Hospital
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0734: Insights into Readmissions of ANCA-Vasculitis Patients: A Nationwide Analysis
    Abstract Poster Presenter: Faria Sami, MD – University of Alabama
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0735: ANCA-associated Vasculitis (AAV) and Long-term Risk of Cardiovascular Disease: Large-scale Propensity-matched Global Retrospective Cohort Study
    Abstract Poster Presenter: Sebastian Klapa, MD (he/him/his) – Universityhospital Schleswig-Holstein; University of Lübeck; Clinic of Rheumatology and Clinical Immunology
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0736: Treatment of IgG4-Related Disease (IgG4-RD) with Elotuzumab, an Inhibitor of SLAM-F7: Report of a Phase 2 Clinical Trial
    Abstract Poster Presenter: John Stone, MD,MPH – Massachusetts General Hospital , Harvard Medical School
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0737: Rurality and Delayed Diagnosis of Giant Cell Arteritis – a Single Center Experience
    Abstract Poster Presenter: Ruoning (Lemon) Ni, MD (she/her/hers) – Cleveland Clinic
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0738: Quantitative Vascular US Has Additional Diagnostic and Prognostic Value in GCA
    Abstract Poster Presenter: Colm Kirby, MD – Tallaght University Hospital
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0739: One Year Outcomes in Those with Isolated PMR Recruited via a Fast Track PMR Clinic
    Abstract Poster Presenter: Patricia Harkins, MD – Trinity College Dublin
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0740: Evaluation of an Accelerated Physical Aging Phenotype in Newly Diagnosed Patients with Polymyalgia Rheumatica
    Abstract Poster Presenter: Patricia Harkins, MD – Trinity College Dublin
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0741: Serum Markers of Disease Activity in Polymyalgia Rheumatica
    Abstract Poster Presenter: Patricia Harkins, MD – Trinity College Dublin
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0742: Use of FDG-PET to Monitor Disease Activity in Patients with Giant Cell Arteritis on Tocilizumab
    Abstract Poster Presenter: Kaitlin Quinn, MD, MHS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0743: Higher Baseline FDG Musculoskeletal Uptake at PET/CT Is Associated with a Higher Remission Rate in Polymyalgia Rheumatica: A Retrospective 3-year Observational Study
    Abstract Poster Presenter: Elvis Hysa, MD – University of Genoa
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0744: Cerebrovascular Accidents (CVA) in Giant Cell Arteritis: Identification of Predictive Factors from the ARTESER Registry
    Abstract Poster Presenter: Adrián Martín-Gutiérrez, -None- – Hospital Universitario Marques de Valdecilla
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0745: Tocilizumab in Monotherapy vs. Combined in Aortitis Associated with Giant Cell Arteritis. Multicenter Open-label Study of 196 Patients
    Abstract Poster Presenter: Adrián Martín-Gutiérrez, -None- – Hospital Universitario Marques de Valdecilla
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0746: Single-cell RNA-Seq Analysis Reveals Distinct Compositional Characterizations and Transcriptomic Profiles of Macrophages in Takayasu’s Arteritis
    Abstract Poster Presenter: Lihong Du, n/a – Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0747: Clofutriben to Improve the Benefit-Risk Profile of Prednisolone in Patients with Polymyalgia Rheumatica
    Abstract Poster Presenter: David Katz, PhD (he/him/his) – Sparrow Pharmaceuticals
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0748: Effectiveness of Interleukin-6 Receptor Inhibitors versus Conventional Synthetic Immunomodulatory Therapy for Treatment of Frail Patients with Polymyalgia Rheumatica
    Abstract Poster Presenter: Sebastian Sattui, MD,MS – University of Pittsburgh
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0749: Age at Disease Onset Influences the Clinical Phenotype and Outcome of Patients with Takayasu Arteritis: Results from a Monocentric Cohort of 167 Patients
    Abstract Poster Presenter: Alessandro Tomelleri, MD,PhD – IRCCS San Raffaele Hospital, Milan, Italy
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0750: Corticosteroid Withdrawal Using Tocilizumab and Its Association with Autoantibody Profile in Takayasu Arteritis: A Multicenter, Single-arm, Prospective Study
    Abstract Poster Presenter: Tsuyoshi Shirai, MD, PhD – Tohoku University
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0751: Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry
    Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0752: Non-classical Organ Involvement in Giant Cell Arteritis
    Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0753: Treatment and Evolution in 134 Patients with Aortitis and Periaortitis. Experience of a Single Referral Centre
    Abstract Poster Presenter: CARMEN SECADA GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0754: Clinical Characterization of Aortitis and Periaortitis in a Cohort of 134 Patients from a Single Universitary Center. A Model-based Cluster Analysis
    Abstract Poster Presenter: CARMEN SECADA GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0755: Characteristics Associated with Long-Term Glucocorticoids Use in Patients with New Onset Polymyalgia Rheumatica
    Abstract Poster Presenter: Anisha Dua, MD, MPH – Northwestern University
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0756: Effectiveness and Safety of Tocilizumab in the Treatment of Polymyalgia Rheumatica: A Meta-Analysis
    Abstract Poster Presenter: Nouman Shafique, MD – AdventHealth
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0757: Regulation of Macrophage Differentiation by Serum Adiponectin: A Novel Mechanism to Increase Alternatively Activated Macrophages During the Remission Phase of Giant Cell Arteritis
    Abstract Poster Presenter: Anna Kernder, n/a – Clinic for Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine-University, Düsseldorf, Germany.
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0758: Difficult to Treat Takayasu Arteritis: Comparative Efficacy of Colchicine and Tofacitinib
    Abstract Poster Presenter: Ravi Kumar U, DM – Christian Medical college, Vellore, India
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0759: Macrophage-Lineage Cells in Giant Cell Arteritis Express MMP12, Phagocytosis and Osteoclast-associated Molecules That May Contribute to Destruction of the Tunica Media
    Abstract Poster Presenter: Makoto Sugihara, MD, PhD (he/him/his) – Tokyo Metropolitan Tama-Hokubu Medical Center
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0760: A Macrophage-smooth Muscle Cell Axis Influences Vascular Remodeling Through Activation of the EGFR Pathway in Giant Cell Arteritis
    Abstract Poster Presenter: Kevin Chevalier, MSc – Université Paris Cité
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0761: An Observational Study of Lifetime Prevalence of Thromboembolism Among Patients with Giant Cell Arteritis
    Abstract Poster Presenter: Ioannis Koulas, MD, MSc – Jacobi Medical Center/Albert Einstein College of Medicine
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0762: Different Giant Cell Arteritis Phenotypes May Present Distinct Types of Ischemic Complications
    Abstract Poster Presenter: HELENA M AMAR MUÑOZ, MD – Hospital General Universitario Gregorio Marañón
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0763: Transcriptional Analysis of Both Normal and Abnormal TABs in Biopsy-proven GCA Reveals a Shared Gene Expression Profile Compared to Clinically Diverse Controls
    Abstract Poster Presenter: Ingrid Lindquist, MD – Veterans Affairs
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0764: Primary Treatment Failure to Tocilizumab in Giant Cell Arteritis
    Abstract Poster Presenter: Paul Cioni, MD – Cochin University Hospital
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0765: Tocilizumab in Extracranial Large-Vessel Giant Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study
    Abstract Poster Presenter: Carmen Lasa Teja, MD – Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0766: Neutrophil Transcriptomics in VEXAS Syndrome
    Abstract Poster Presenter: Chloe Palmer, BS – National Institutes of Health, NIAMS
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0767: Comparing Large Vessel Uptake of 68Ga-HA-DOTATATE to 18F-FDG Using PET/CT Imaging in Patients with Active Giant Cell Arteritis
    Abstract Poster Presenter: Alison Clifford, MD, FRCPC, MSc (she/her/hers) – University of Alberta
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0768: Addressing Gaps in Polymyalgia Rheumatica: A Systematic Literature Review
    Abstract Poster Presenter: Angela Degrassi, BS (she/her/hers) – Global Healthy Living Foundation
    Vasculitis
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0769: Baseline Evaluation of Diagnoses and Prescribing Patterns in Polymyalgia Rheumatica
    Abstract Poster Presenter: Laura Stradford, MPH – Global Healthy Living Foundation
    Vasculitis
  • Saturday, Nov 16th
    11:30 AM – 12:30 PM Eastern Time
    MTP05B: Meet the Professor: Vasculitis
    Location: Room 148
    Seminar Presenter: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
     CME 1 hours
  • Saturday, Nov 16th
    1:00 PM – 2:30 PM Eastern Time
    16S57: Abstracts: Vasculitis – ANCA-Associated I
    Location: Room 150AB
    Abstract Moderator: Matthew Koster, MD, RhMSUS – Mayo Clinic
    Abstract Moderator: Zachary Wallace, MD;MSc – Massachusetts General Hospital
    Vasculitis
     CME 0 hours
  • Saturday, Nov 16th
    1:00 PM – 1:15 PM Eastern Time
    0823: A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis
    Location: Room 150AB
    Presenting Author: Carol Langford, MD;MHS – Cleveland Clinic
    Vasculitis
  • Saturday, Nov 16th
    1:15 PM – 1:30 PM Eastern Time
    0824: The Effect of Intranasal Niclosamide on Nasal Symptoms in Patients with ENT Manifestations of ANCA-Associated Vasculitis (AAV): Post Hoc Analysis of Subset of Patients Recruited to the PROTECT-V Trial
    Location: Room 150AB
    Presenting Author: Benjamin Lim, n/a – University of Cambridge
    Vasculitis
  • Saturday, Nov 16th
    1:30 PM – 1:45 PM Eastern Time
    0825: Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (BRAVO): 6-month Outcomes of a Longitudinal Cohort Study
    Location: Room 150AB
    Presenting Author: Arielle Mendel, MD, FRCPC, MSc (she/her/hers) – McGill University Health Centre
    Vasculitis
  • Saturday, Nov 16th
    1:45 PM – 2:00 PM Eastern Time
    0826: Plasma Exchange for Severe Alveolar Hemorrhage in ANCA-Associated Vasculitis: Emulation of a Target Trial
    Location: Room 150AB
    Presenting Author: Anne-Claire Sanna, MD – Université Paris Cité
    Vasculitis
  • Saturday, Nov 16th
    2:00 PM – 2:15 PM Eastern Time
    0827: Oral Corticosteroid-Sparing Effects of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis (EGPA): Results up to 7.4 Years from the Long-Term Access Programme
    Location: Room 150AB
    Presenting Author: Emmeline Igboekwe, PharmD – US Medical Affairs-Respiratory, GSK
    Vasculitis
  • Saturday, Nov 16th
    2:15 PM – 2:30 PM Eastern Time
    0828: Efficacy of Eosinophil-Targeting Therapies on Specific Disease Manifestations of Eosinophilic Granulomatosis with Polyangiitis in the Phase 3 MANDARA Trial
    Location: Room 150AB
    Presenting Author: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
  • Sunday, Nov 17th
    9:00 AM – 10:00 AM Eastern Time
    17S03: Controversies in the Treatment of ANCA-Associated Vasculitis
    Location: Ballroom B
    Moderator: Anisha Dua, MD, MPH – Northwestern University
    Moderator: Kaitlin Quinn, MD, MHS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Vasculitis
     CME 1 hours
  • Sunday, Nov 17th
    9:00 AM – 9:30 AM Eastern Time
    Treatment Guidelines and New Therapeutics for GPA and AAV
    Location: Ballroom B
    Speaker: Carol Langford, MD;MHS – Cleveland Clinic
    Vasculitis
  • Sunday, Nov 17th
    9:30 AM – 10:00 AM Eastern Time
    Current Controversies in Treatment of GPA and MPA
    Location: Ballroom B
    Speaker: Philip Seo, MD – Johns Hopkins University
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    Vasculitis – ANCA-Associated Poster I
    Vasculitis
     CME 0 hours
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    Vasculitis – Non-ANCA-Associated & Related Disorders Poster II
    Vasculitis
     CME 0 hours
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1592: Overlapping Forms of Eosinophilic Granulomatosis with Polyangiitis and Granulomatosis with Polyangiitis: Presentation, Management and Outcomes
    Abstract Poster Presenter: Federica Pallotti, MD – Internal Medicine and Clinical Immunology
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1593: Efficacy of Increasing the Dose of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
    Abstract Poster Presenter: Federica Pallotti, MD – Internal Medicine and Clinical Immunology
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1594: Response to Mepolizumab Therapy in a Single-center Cohort of Eosinophilic Granulomatosis with Polyangiitis Patients: Characterization of Cytokine/Chemokine Pattern and Phenotypic Stratification
    Abstract Poster Presenter: Michele Moretti, MD – University of Pisa
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1595: Tezepelumab for Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis: A European Retrospective Study
    Abstract Poster Presenter: Benjamin Terrier – National Referral Center for Rare Systemic Autoimmune Diseases Paris Cochin
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1596: Efficacy of Eosinophil-Targeting Therapies According to Disease Severity in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Abstract Poster Presenter: Bernhard Hellmich, MD – Medius Kliniken
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1597: Baseline Glucocorticoid-Related Toxicity in Newly-Diagnosed and Relapsing ANCA-Associated Vasculitis
    Abstract Poster Presenter: Naomi Patel, MD,MPH – Massachusetts General Hospital
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1598: Projecting the Impact of Standard, Reduced-Dose, and Minimal-Dose Glucocorticoid Regimens in the Treatment of ANCA-Associated Vasculitis Using Simulation Modeling
    Abstract Poster Presenter: Naomi Patel, MD,MPH – Massachusetts General Hospital
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1599: Glucocorticoids versus Glucocorticoids Plus Cyclophosphamide in Eosinophilic Granulomatosis with Polyangiitis with Poor-Prognosis Factors: A Target Trial Emulation Study
    Abstract Poster Presenter: Boris Sorin, MD, PhD – Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases of Ile de France, East and West, Paris Cité University, Assistance Publique – Hôpitaux de Paris
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1600: Glucocorticoids versus Glucocorticoids Plus Cyclophosphamide in Eosinophilic Granulomatosis with Polyangiitis Without Poor-Prognosis Factors: A Target Trial Emulation Study
    Abstract Poster Presenter: Boris Sorin, MD, PhD – Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases of Ile de France, East and West, Paris Cité University, Assistance Publique – Hôpitaux de Paris
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1601: Changing Spectrum of Systemic Therapies for Eosinophilic Granulomatosis with Polyangiitis from 2006-2023
    Abstract Poster Presenter: Lynn Fussner, MD – The Ohio State University
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1602: Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA) Patients: A Nationwide Analysis
    Abstract Poster Presenter: Faria Sami, MD – University of Alabama
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1603: Antineutrophil Cytoplasmic Autoantibody Levels in Patients in the Avacopan Phase 3 Trial
    Abstract Poster Presenter: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1604: Utilizing Machine Learning with Claims Data to Diagnose and Quantify the Prevalence of Eosinophilic Granulomatosis with Polyangiitis
    Abstract Poster Presenter: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1605: Characteristics of Relapses in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Abstract Poster Presenter: Christian Pagnoux, MD,MSc,MPH – Mount Sinai Hospital
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1606: Demographic and Treatment Patterns in Patients with Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Cohort Analysis of US Claims and Clinical Data
    Abstract Poster Presenter: Stephanie Chen, PhD – AstraZeneca Pharmaceuticals LP
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1607: Low Concentrations of Anti-C5a Complement Receptor Antibodies Are Associated with Relapse in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
    Abstract Poster Presenter: Sebastian Klapa, MD (he/him/his) – Universityhospital Schleswig-Holstein; University of Lübeck; Clinic of Rheumatology and Clinical Immunology
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1608: Interstitial Lung Disease in ANCA-associated Vasculitis: A Retrospective Study of Clinical Characteristics, Radiographic Features, and Outcomes
    Abstract Poster Presenter: Janelle Castellino, MD, PharmD (she/her/hers) – Rush University Medical Center
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1609: Characteristics of a Cohort of Patients with Interstitial Lung Disease and ANCA Positivity in a University Hospital
    Abstract Poster Presenter: Cristina Valero, MD – Hospital de la Princesa
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1610: Anti-neutrophil Cytoplasmic Antibodies Associated Interstitial Pneumonia: A New Clinical Entity?
    Abstract Poster Presenter: Claudia Iannone, MD – University of Milan, Gaetano Pini CTO
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1611: Impact of Mepolizumab on Patient-reported Outcomes in Eosinophilic Granulomatosis with Polyangiitis by Using the ANCA-associated Vasculitis Patient-reported Outcomes (AAV-PRO) Questionnaire: A European Multicentre Prospective Study
    Abstract Poster Presenter: Paolo Delvino, MD, PhD – University of Milano-Bicocca
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1612: Arterial Involvement Distribution on 18FFDG PET-CT in Giant Cell Arteritis: Variances Based on Clinical Phenotype
    Abstract Poster Presenter: Paola Vidal Montal, -None- – Bellvitge University Hospital
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1613: Adherence to Dietary Recommendations and the Risk of Developing Giant Cell Arteritis; A Nested Case-Control Study
    Abstract Poster Presenter: Carl Turesson, MD, PhD – Lund University
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1614: Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry
    Abstract Poster Presenter: Juan Molina-Collada, MD – Hospital General Universitario Gregorio Marañón
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1615: Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study
    Abstract Poster Presenter: Haner Direskeneli, MD – Marmara University
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1616: Vitamin D Supplementation in the Prevention of Severe Adverse Effects Caused ByGlucocorticoids: Study from the ARTESER Registry of Giant Cell Arteritis
    Abstract Poster Presenter: Gaston Ghio, MD (he/him/his) – Hospital Universitari Mutua de Terrassa
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1617: Persistence of Imaging Abnormality in Patients with Large Vessel Vasculitis Despite Clinical Remission
    Abstract Poster Presenter: Luigi Boiardi, MD,PhD – Ausl Reggio Emilia
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1618: Co-occurrence of Giant Cell Arteritis and Polymyalgia Rheumatica: Insights from a Retrospective Analysis
    Abstract Poster Presenter: Vivekanand Tiwari, MBBS – Dartmouth Hitchcock Medical Center
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1619: Challenges in Managing Polymyalgia Rheumatica and Giant Cell Arteritis: Steroid Dependence and Preventive Care
    Abstract Poster Presenter: Vivekanand Tiwari, MBBS – Dartmouth Hitchcock Medical Center
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1620: Unveiling of a New Molecular Imaging Biomarker? Vascular Adhesion Protein-1 and [68Ga]Ga-DOTA-Siglec-9 PET/CT in Detecting Giant Cell Arteritis Relapse
    Abstract Poster Presenter: Simon Petzinna, MD – University Hospital Bonn
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1621: Analysis of Hospitalizations of Adult Patients with Kawasaki’s Disease: A United States Population Based Study
    Abstract Poster Presenter: Ufuoma Mamoh, MBChB – Medstar Union Memorial Hospital
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1622: 18F-FDG PET/CT in LVV During Active and Inactive Disease Phases Is Associated with the Metabolic Profile, but Not with Macrophage-related Cytokines: Results of an Integrated Analysis
    Abstract Poster Presenter: Loukas Chatzis, MD – Pathophysiology Department, Athens School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1623: Sex Differences in Phenotypes and Imaging Examination in Giant Cell Arteritis: Data from the ARTESER Registry
    Abstract Poster Presenter: Delia Fernandez-Lozano, MD – Hospital Clínico Universitario de Valencia
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1624: Prognostic Value of Baseline 18F-FDG PET/CT Scan in Giant Cell Arteritis with Large Vessel Involvement
    Abstract Poster Presenter: Julio Sanchez Martin, MD – Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1625: Impacts of a Fast-Track Referral Clinic on Health Care Utilization, Delays and Complications in Patients with Giant Cell Arteritis
    Abstract Poster Presenter: Alae Dhahbi, -None- – Hôpital Sacré-Coeur de Montréal
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1626: Intracranial Giant Cell Arteritis: A Comprehensive Systematic Review
    Abstract Poster Presenter: Mats Junek, MD, MSc – McMaster University
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1627: Real-World Data on Imaging Tests, Specifically Temporal Artery Ultrasound, in Giant Cell Arteritis in Japan: A Multicenter Retrospective Study
    Abstract Poster Presenter: Nobuhiro Oda, MD – Kameda medical center
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1628: Tocilizumab for Giant Cell Arteritis in Japan over 2 Years: A Multicenter Retrospective Study
    Abstract Poster Presenter: Nobuhiro Oda, MD – Kameda medical center
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1629: Subclinical Giant Cell Arteritis in Polymyalgia Rheumatica Has a Different Vascular Ultrasound Phenotype Than Giant Cell Arteritis
    Abstract Poster Presenter: David Kane, PhD,FRCP – Tallaght University Hospital & Trinity College Dublin
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1630: Disease Manifestations, Diagnostic Findings, and Mortality of 120 Consecutive Patients Suspected of Giant Cell Arteritis – Results from a Hospital GCA Fast-Track Clinic
    Abstract Poster Presenter: Uffe Moller Dohn, MD,PhD – Rigshospitalet-Glostrup
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1631: Serum IL-6 Levels Correlate with Inflammatory Activity in Computerized Tomography Angiography Scans in Takayasu Arteritis
    Abstract Poster Presenter: Ana luisa Souza Pedreira, Ana Luisa Pedreira – Escola Bahiana de Medicina
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1632: Multi-vessel Intimal Medial Thickness in Takayasu Arteritis: A Potential Marker for Disease Modification?
    Abstract Poster Presenter: Molly Thabah, MD (she/her/hers) – Jawaharlal Institute of Postgraduate Medical Education and Research
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1633: Arthritis Activity Significantly Affects Quality of Life in Behcet's Disease Patients
    Abstract Poster Presenter: Koichi Sugihara, MD – Kagawa University
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1634: A Lexicon of Signs and Symptoms of Giant Cell Arteritis: An International Expert Consensus
    Abstract Poster Presenter: Milena Bond, MD – Azienda sanitaria dell'Alto Adige
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1635: Magnetic Resonance Imaging for Therapy Monitoring in Giant Cell Arteritis – Impact on Disease Management
    Abstract Poster Presenter: Marc Schmalzing, MD – University Hospital Wuerzburg
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1636: Age-associated B Cells Contribute to Inflammation of Takayasu’s Arteritis in an Antibody-secreting Cell Differentiation Independent Manner
    Abstract Poster Presenter: Chenglong Fang, n/a – Department of Rheumatology, Second Affiliated Hospital of Fujian Medical University
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1637: Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome
    Abstract Poster Presenter: Pablo Francisco Muñoz Martínez, MD – Hospital Universitario y Politécnico La Fe
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1638: Calprotectin, a Mechanistically Informed Biomarker for Clinically Isolated Aortitis
    Abstract Poster Presenter: Katarina Kmetova, PhD, BSc, MSc – Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1639: Ultrasound Fast-Track Giant Cell Arteritis Clinic Experience in the United States
    Abstract Poster Presenter: Mark Matza, MD, MBA, RhMSUS – Massachusetts General Hospital
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1640: ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis
    Abstract Poster Presenter: Eugenio De Miguel, MD,PhD – Hospital Universitario La Paz
    Vasculitis
  • Sunday, Nov 17th
    10:30 AM – 12:30 PM Eastern Time
    1641: Orbital MRI as a Promising Approach for the Diagnosis of Giant Cell Arteritis in Case of Anterior Ischemic Optical Neuropathy or Central Retinal Artery Occlusion
    Abstract Poster Presenter: Maxime SAMSON, MD,PhD – Dijon University Hospital
    Vasculitis
  • Sunday, Nov 17th
    11:30 AM – 12:30 PM Eastern Time
    MTP13A: Meet the Professor: Vasculitis Mimics
    Location: Room 154B
    Seminar Presenter: Philip Seo, MD – Johns Hopkins University
    Vasculitis
     CME 1 hours
  • Sunday, Nov 17th
    1:00 PM – 2:30 PM Eastern Time
    17S58: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: Clinical Trials
    Location: Room 207AB
    Abstract Moderator: Mike Putman, MD, MSc – The Medical College of Wisconsin
    Abstract Moderator: Megan Sullivan, MD, RhMSUS – Mayo Clinic Arizona
    Vasculitis
     CME 0 hours
  • Sunday, Nov 17th
    1:00 PM – 1:15 PM Eastern Time
    1695: Efficacy of Upadacitinib in Patients with Giant Cell Arteritis: Subgroup Analysis of the SELECT-GCA Phase 3 Trial
    Location: Room 207AB
    Presenting Author: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
  • Sunday, Nov 17th
    1:15 PM – 1:30 PM Eastern Time
    1696: Comparison of Mycophenolate Mofetil Plus Methotrexate versus Cyclophosphamide with Sequential Azathioprine for Active Takayasu's Arteritis: An Open-Label, Randomized-Controlled Trial
    Location: Room 207AB
    Presenting Author: XIAOCHUAN SUN, MD (he/him/his) – Peking Union Medical College Hospital
    Vasculitis
  • Sunday, Nov 17th
    1:30 PM – 1:45 PM Eastern Time
    1697: Results of a One Year Randomized Double-Blind Placebo-Controlled Trial with Methotrexate 25mg Per Week for Recently Diagnosed PolyMyalgia Rheumatica
    Location: Room 207AB
    Presenting Author: Thomas Bolhuis, MSc,MD – Sint Maartenskliniek
    Vasculitis
  • Sunday, Nov 17th
    1:45 PM – 2:00 PM Eastern Time
    1698: Assessment of the Remission Maintenance After Tocilizumab Withdrawal in Polymyalgia Rheumatica Patients Receiving a 6-month Treatment
    Location: Room 207AB
    Presenting Author: Baptiste Chevet, MD, MSc (he/him/his) – University Hospital of Brest
    Vasculitis
  • Sunday, Nov 17th
    2:00 PM – 2:15 PM Eastern Time
    1699: Anakinra in Giant Cell Arteritis: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
    Location: Room 207AB
    Presenting Author: Hubert de Boysson, MD,PhD – Caen university Hospital
    Vasculitis
  • Sunday, Nov 17th
    2:15 PM – 2:30 PM Eastern Time
    1700: Comparative Effectiveness of Sarilumab vs. Methotrexate as a Glucocorticoid-Sparing Agent in Patients with Polymyalgia Rheumatica
    Location: Room 207AB
    Presenting Author: Jeffrey R. Curtis, MD, MS, MPH – University of Alabama at Birmingham
    Vasculitis
  • Sunday, Nov 17th
    3:30 PM – 5:00 PM Eastern Time
    17S48: Development of Treatment Response Criteria for Giant Cell Arteritis
    Location: Ballroom A
    Moderator: Michelle Burke, APRN, CNP, MS – Mayo Clinic
    Moderator: Carol Langford, MD;MHS – Cleveland Clinic
    Vasculitis
     CME 1.5 hours
  • Sunday, Nov 17th
    3:30 PM – 4:00 PM Eastern Time
    Outcome Assessment in Giant Cell Arteritis Clinical Trials and Observational Studies
    Location: Ballroom A
    Speaker: Milena Bond, MD – Azienda sanitaria dell'Alto Adige
    Vasculitis
  • Sunday, Nov 17th
    4:00 PM – 4:30 PM Eastern Time
    Challenges Related to the Measurement of Treatment Response in GCA
    Location: Ballroom A
    Speaker: Christian Dejaco, MD;PhD;MBA – Azienda Sanitaria Alto Adige
    Vasculitis
  • Sunday, Nov 17th
    4:30 PM – 5:00 PM Eastern Time
    Methodological Steps for the Development of Response Criteria in Giant Cell Arteritis
    Location: Ballroom A
    Speaker: Zahi Touma, MD;PhD – University of Toronto
    Vasculitis
  • Sunday, Nov 17th
    4:30 PM – 5:30 PM Eastern Time
    MTP13B: Meet the Professor: Vasculitis Mimics
    Location: Room 154B
    Seminar Presenter: Philip Seo, MD – Johns Hopkins University
    Vasculitis
     CME 1 hours
  • Monday, Nov 18th
    10:00 AM – 11:30 AM Eastern Time
    18M16: Takayasu Arteritis: Pearls, Pitfalls, and Mimics
    Location: Ballroom C
    Moderator: Tanaz Kermani, MD;MS – University of California Los Angeles
    Moderator: Curry Koening, MD;MS – University of Texas Dell Medical School
    Vasculitis
     CME 1.5 hours
  • Monday, Nov 18th
    10:00 AM – 10:30 AM Eastern Time
    Imaging Modalities in Takayasu Arteritis
    Location: Ballroom C
    Speaker: Kaitlin Quinn, MD, MHS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 11:00 AM Eastern Time
    Therapeutic and Management Considerations in Takayasu Arteritis
    Location: Ballroom C
    Speaker: Jason Springer, MD,MS – Vanderbilt University Medical Center
    Vasculitis
  • Monday, Nov 18th
    11:00 AM – 11:30 AM Eastern Time
    Large Vessel Vasculitis Mimics
    Location: Ballroom C
    Speaker: Jeffrey Olin, DO – Icahn School of Medicine at Mount Sinai
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    Vasculitis – ANCA-Associated Poster III
    Vasculitis
     CME 0 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
    Vasculitis
     CME 0 hours
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2478: Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis Without Kidney Involvement in a Phase 3 Trial
    Abstract Poster Presenter: Christian Pagnoux, MD,MSc,MPH – Mount Sinai Hospital
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2479: Mepolizumab Treatment Decreased Oral Corticosteroid Use and Improved Clinical Response, Control Status, and Remission in Patients with Eosinophilic Granulomatosis with Polyangiitis: Results up to 24 Months from a Large Network of US Allergy Practices
    Abstract Poster Presenter: Amy G. Edgecomb, PharmD, MPH – US Value, Evidence, & Outcomes, Anti-Infectives and Respiratory, GSK
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2480: Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis and Ear, Nose, or Throat Involvement in a Phase 3 Trial
    Abstract Poster Presenter: Robert Spiera, MD – Hosptial for Special Surgery
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2481: General, Nervous System, Eye, and Skin Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
    Abstract Poster Presenter: Rula A. Hajj-Ali, MD – Cleveland Clinic
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2482: Long-Term Safety of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis (EGPA): Pooled Results from Two Open-Label Extension Studies
    Abstract Poster Presenter: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2483: Efficacy and Safety of Avacopan over 12 Months in Japanese Patients with MPA/GPA: A Single-center Study
    Abstract Poster Presenter: Yusuke Ushio, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2484: Real-World Use of Avacopan for ANCA-Associated Vasculitis Beyond 52 Weeks
    Abstract Poster Presenter: Julia Ford, MD – University of Michigan
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2485: Orbital Pseudotumor in Granulomatosis with Polyangiitis. Interim Analysis of Clinical Outcomes from a European Collaborative Observational Study
    Abstract Poster Presenter: Luca Moroni, MD,MMSc – IRCCS Ospedale San Raffaele
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2486: Glucocorticoids May Mitigate the Risk of Avacopan-Induced Liver Dysfunction in ANCA-Associated Vasculitis: Data from a Multicenter Observational Study in Japan
    Abstract Poster Presenter: Tomohisa Uchida, MD – Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2487: Comparing Circulating Protein Profiles in Patients with Active Myeloperoxidase (MPO) vs Proteinase-3 (PR3) Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
    Abstract Poster Presenter: Zachary Wallace, MD;MSc – Massachusetts General Hospital
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2488: Patient Characteristics and Treatment Patterns Before and After Initiation of Avacopan in the United States: An Early View Based on a Claims Database Analysis
    Abstract Poster Presenter: Zachary Wallace, MD;MSc – Massachusetts General Hospital
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2489: Avacopan for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) in a Real-World Setting
    Abstract Poster Presenter: Zachary Wallace, MD;MSc – Massachusetts General Hospital
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2490: Longitudinal Kidney Function Trajectories in Patients Enrolled in the Plasma Exchange and Glucocorticoids in ANCA-Associated Vasculitis Trial
    Abstract Poster Presenter: Jennifer Hanberg, MD – Brigham and Women's Hospital
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2491: Treatment Outcomes of Eosinophilic Granulomatosis with Polyangiitis (EGPA):A Retrospective Analysis of US Health Insurance Claims Data
    Abstract Poster Presenter: Stephanie Chen, PhD – AstraZeneca Pharmaceuticals LP
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2492: ANCA Associated Tracheobronchial Disease
    Abstract Poster Presenter: Megan Sullivan, MD, RhMSUS – Mayo Clinic Arizona
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2493: Mortality in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: Study from a Single University Hospital
    Abstract Poster Presenter: Fabricio Benavides, MD (he/him/his) – Hospital Universitario Marqués de Valdecilla
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2494: Clinical Characteristics, Predictors for Mortality and Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score on Survival in ANCA-associated Vasculitis in Hong Kong : A Multi-centre Retrospective Cohort Study
    Abstract Poster Presenter: Ka Ho Yeung, MBBS, MRCP – Caritas Medical Centre
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2495: Diffuse Alveolar Hemorrhage in Patient with ANCA-associated Vasculitis AndInterstitial Lung Disease
    Abstract Poster Presenter: Elif Ediboglu, M.D. – Mayo Clinic
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2496: Clinical Features and Outcomes of Hydralazine-associated Vasculitis: A Case-Control Study
    Abstract Poster Presenter: Elif Ediboglu, M.D. – Mayo Clinic
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2497: Clinical Characteristics and Outcomes of Hydralazine-induced ANCA-associated Vasculitis. a Single Center Retrospective Cohort Analysis from the US
    Abstract Poster Presenter: Muhammad Shamim, DO – University Hospitals/ Case Western Reserve University
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2498: The Methylome Profile of B-cells as a Biomarker of Nephritis in IgA Vasculitis
    Abstract Poster Presenter: Verónica Pulito Cueto, PhD – IDIVAL
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2499: Description of Patients with Kawasaki Disease Shock Syndrome at a Large Tertiary Center
    Abstract Poster Presenter: Jessica Nguyen, MD – Baylor College of Medicine
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2500: Description of Patients with Refractory Kawasaki Disease at a Large Tertiary Center
    Abstract Poster Presenter: Jessica Nguyen, MD – Baylor College of Medicine
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2501: Long-term Remission off Therapy (LTROT) Is Possible in Non-infectious Aortitis with DMARDs with Low Risk of Secondary Adrenal Insufficiency
    Abstract Poster Presenter: Shirish Dubey, MBBS, FRCP, MMed (he/him/his) – Oxford University Hospitals NHS FT
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2502: Characterization of the Tissue Fibroblast Repertoire in IgG4-Related Ophthalmic Disease
    Abstract Poster Presenter: Eduardo Martin-Nares, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2503: Hypothalamic-Pituitary-Adrenal Axis Suppression by Prednisolone Reversed by the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Clofutriben
    Abstract Poster Presenter: David Katz, PhD (he/him/his) – Sparrow Pharmaceuticals
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2504: Polyarteritis Nodosa Associated with VEXAS Syndrome and Chronic Myelomonocytic Leukemia Compared with Primary Forms: A Case-Control Study
    Abstract Poster Presenter: Paul Cioni, MD – Université Paris Cité
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2505: C5 Signaling Pathway Genes as Key Drivers of the Pathogenesis of IgA Vasculitis?
    Abstract Poster Presenter: Joao Carlos Batista-Liz, MSc – IDIVAL
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2506: THP1-derived Macrophage Polarization in Takayasu Arteritis – Impact of Disease Status and Therapy
    Abstract Poster Presenter: Alexandre de Souza, MD, PhD (he/him/his) – UNIFESP-EPM
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2507: IgG4-related Disease Features and Immunological Profile in a Tertiary Center in Sao Paulo-Brazil
    Abstract Poster Presenter: Alexandre de Souza, MD, PhD (he/him/his) – UNIFESP-EPM
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2508: The Impact of Lipid Profile Parameters on the Incidence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients: A Single-arm Meta-Analysis
    Abstract Poster Presenter: Nouman Shafique, MD – AdventHealth
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2509: Bone Marrow Failure in VEXAS Is Associated with the Degree of UBA1b Deficiency
    Abstract Poster Presenter: Benjamin Turturice, MD PhD – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2510: The Effect of Coronary Artery Aneurysms and IVIG Use on Long-term Cardiovascular Disease and Mortality Following Kawasaki Disease in Childhood: A Systematic Review and Meta-analysis
    Abstract Poster Presenter: Francis Lao, MD, BSc – McMaster University, University of Toronto
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2511: Clinical Characteristics and Outcomes of Patients with Clinically Isolated Aortitis
    Abstract Poster Presenter: Mahmut Kaymakci, MD – University of Pittsburgh Medical Center
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2512: French Multicenter Retrospective Study of Patients with Cocaine- and/or Levamisole-induced Vasculitis and Vasculopathy
    Abstract Poster Presenter: Kevin Chevalier, MSc – Université Paris Cité
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2513: Frequency, Diagnosis, and Management of Polymyalgia Rheumatica in Germany – Database Analysis of Medical Insurance Data
    Abstract Poster Presenter: Wolfgang Schmidt, MD,MACR – Immanuel Krankenhaus Berlin
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2514: The Pattern of Renal Involvement in Relapsing Cryoglobulinemic Vasculitis After Successful Sustained Viral Response by Direct-Acting Antiviral Treatments
    Abstract Poster Presenter: Mohamed Tharwat Hegazy, MD – Faculty of Medicine, Cairo University
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2515: Upadacitinib for Refractory Behçet’s Syndrome: A Multi-center, Prospective, Open-label, Pilot Study
    Abstract Poster Presenter: Weiyi Xia, MBBS – Peking University People’s Hospital
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2516: Exome-Wide Rare Variant Association Study of Takayasu’s Arteritis
    Abstract Poster Presenter: Yiming Luo, MD, MHS – Columbia University
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2517: Skin Microbiome Shows Differences Between Pathergy Positive and Negative Patients with Behçet’s Syndrome
    Abstract Poster Presenter: Gülen Hatemi, MD – Istanbul University - Cerrahpasa
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2518: Behçet’s Disease Immune Landscape Exhibits a Universal NF-kB-mediated Hyperactivation Pattern with Cell-specific TNFAIP3 Responses and a Superimposed IFN-regulated Endotype
    Abstract Poster Presenter: Olivier Manches, PhD – NYU Langone
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2519: What Do We Know About Malignancies in IgA Vasculitis?
    Abstract Poster Presenter: Alojzija Hocevar, MD,PhD – University Medical Center Ljubljana
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2520: Prevalence and Incidence of Giant Cell Arteritis Among Medicare Fee-For-Service Beneficiaries: United States, 2014–2019
    Abstract Poster Presenter: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2521: Clinicopathologic Associations Between Macrophage Location and Functional Profile in Giant Cell Arteritis
    Abstract Poster Presenter: Mike Putman, MD, MSc – The Medical College of Wisconsin
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2522: Anticoagulant Treatment May Decrease the Relapse Rate in Pulmonary Arterial Involvement of Behçet’s Disease When Added After the First Event
    Abstract Poster Presenter: Haner Direskeneli, MD – Marmara University
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2523: Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms
    Abstract Poster Presenter: Haner Direskeneli, MD – Marmara University
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2524: Metabolite Profiling of Saliva for the Discrimination of Behcet’s Disease, Sjogren's Syndrome, and Recurrent Aphthous Stomatitis
    Abstract Poster Presenter: Jiwon Hwang, MD, PhD (she/her/hers) – KYUNG HEE UNIVERSITY MEDICAL CENTER
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2525: Challenges and Opportunities in Integrating Sleep Recommendations into Counselling Patients with Arthritis: A Survey of Physical Therapists and Physical Therapy Students
    Abstract Poster Presenter: Codie Primeau, PhD, PT (he/him/his) – University of British Columbia & Arthritis Research Canada
    Vasculitis
  • Monday, Nov 18th
    10:30 AM – 12:30 PM Eastern Time
    2526: Development of the Hospital Emergency Advocacy & Treatment Kit (HEAT Kit) for Patients with Vasculitis
    Abstract Poster Presenter: Sarah Jones, MS, MPA (she/her/hers) – Eosinophilic & Rare Disease Cooperative
    Vasculitis
  • Monday, Nov 18th
    1:00 PM – 2:00 PM Eastern Time
    18M32: Pediatric ANCA-Associated Vasculitis
    Location: Room 204ABC
    Moderator: Jessica Bloom, MD;MS – University of Colorado
    Moderator: Andrew Zeft, MD,MPH – Cleveland Clinic
    Vasculitis
     CME 1 hours
  • Monday, Nov 18th
    1:00 PM – 1:30 PM Eastern Time
    Organ-Specific Outcomes in Pediatric ANCA-Associated Vasculitis: Influence on Diagnosis and Treatment: Management of ANCA for Pediatrics
    Location: Room 204ABC
    Interactive Speaker: Kimberly Morishita, MD – University of British Columbia - Vancouver
    Vasculitis
  • Monday, Nov 18th
    1:30 PM – 2:00 PM Eastern Time
    Management of Pediatric ANCA-Associated Vasculitis: Lessons Learned from the Adults
    Location: Room 204ABC
    Interactive Speaker: Peter Merkel, MD,MPH – University of Pennsylvania
    Vasculitis
  • Monday, Nov 18th
    3:00 PM – 4:30 PM Eastern Time
    18M71: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders II
    Location: Ballroom B
    Abstract Moderator: Kaitlin Quinn, MD, MHS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Abstract Moderator: Mina Al-Awqati, MD – University of Illinois
    Vasculitis
     CME 0 hours
  • Monday, Nov 18th
    3:00 PM – 3:15 PM Eastern Time
    2647: Clinical Characteristics , Treatment Outcomes and Predictors of Mortality in a DADA2 Cohort of 101 Patients
    Location: Ballroom B
    Presenting Author: Aman Sharma, MD,MBBS,FRCP (he/him/his) – PGIMER, Chandigarh, India
    Vasculitis
  • Monday, Nov 18th
    3:15 PM – 3:30 PM Eastern Time
    2648: Diagnosis of Giant Cell Arteritis by 18F-FDG PET/CT in Patients on Glucocorticoid Therapy: Importance of Delayed Imaging
    Location: Ballroom B
    Presenting Author: Vicente Aldasoro Caceres, MD,PhD – Hospital Universitario de Navarra
    Vasculitis
  • Monday, Nov 18th
    3:30 PM – 3:45 PM Eastern Time
    2649: Defining Clinical Subgroups of Patients with Relapsing Polychondritis: A Latent Class and Decision Tree Analysis in Two Independent Prospective Cohorts
    Location: Ballroom B
    Presenting Author: Marcela Ferrada, MD – University of Maryland
    Vasculitis
  • Monday, Nov 18th
    3:45 PM – 4:00 PM Eastern Time
    2650: Extent of Vascular Inflammation on Cranial Vessel Wall MRI and Ophthalmic Complications in Giant Cell Arteritis
    Location: Ballroom B
    Presenting Author: David Yang, BA (he/him/his) – University of Pennsylvania
    Vasculitis
  • Monday, Nov 18th
    4:00 PM – 4:15 PM Eastern Time
    2651: Vasculitis Associated with VEXAS Syndrome
    Location: Ballroom B
    Presenting Author: Megan Sullivan, MD, RhMSUS – Mayo Clinic Arizona
    Vasculitis
  • Monday, Nov 18th
    4:15 PM – 4:30 PM Eastern Time
    2652: Characteristics of Relapse and Therapeutic Management in Giant Cell Arteritis in Modern Era, NEWTON Study
    Location: Ballroom B
    Presenting Author: Geoffroy Peyrac, JD – Université de Paris
    Vasculitis
  • Tuesday, Nov 19th
    8:15 AM – 9:15 AM Eastern Time
    19T01: Cerebral Crossroads: Primary Central Nervous System Angiitis in Children Explained
    Location: Room 144ABC
    Moderator: Ekemini Ogbu, MD,MSc – Cincinnati Children's Hospital Medical Center
    Moderator: Smriti Mohan, MD – University of Michigan
    Vasculitis
     CME 1 hours
  • Tuesday, Nov 19th
    8:15 AM – 8:45 AM Eastern Time
    Clinical Features and Novel Biomarkers of Primary Angiitis of the Central Nervous System in Children
    Location: Room 144ABC
    Interactive Speaker: Eyal Muscal, MD,MS – Baylor College of Medicine
    Vasculitis
  • Tuesday, Nov 19th
    8:45 AM – 9:15 AM Eastern Time
    A Multidisciplinary Approach to Management of Primary Angiitis of the Central Nervous System in Children
    Location: Room 144ABC
    Interactive Speaker: Heather Van Mater, MD, MS – Duke University
    Vasculitis
  • Tuesday, Nov 19th
    11:00 AM – 12:30 PM Eastern Time
    19T17: Abstracts: Vasculitis – ANCA-Associated II
    Location: Room 103AB
    Abstract Moderator: Tanaz Kermani, MD;MS – University of California Los Angeles
    Abstract Moderator: Rennie Rhee, MD, MS – University of Pennsylvania
    Vasculitis
     CME 0 hours
  • Tuesday, Nov 19th
    11:00 AM – 11:15 AM Eastern Time
    2689: Characterization of Alpha-1 Antitrypsin Function in ANCA-Associated Vasculitis
    Location: Room 103AB
    Presenting Author: Lynn Fussner, MD – The Ohio State University
    Vasculitis
  • Tuesday, Nov 19th
    11:15 AM – 11:30 AM Eastern Time
    2690: ANCA IgG Promotion of Neutrophil Recruitment, Migration and Vascular Damage in ANCA Associated Vasculitis May Be Enhanced by Hypoxia
    Location: Room 103AB
    Presenting Author: Noelle Pisacano, BSc, MSc, PhD – Imperial College London
    Vasculitis
  • Tuesday, Nov 19th
    11:30 AM – 11:45 AM Eastern Time
    2691: Transcriptomic Changes in CD4+ T Lymphocytes in Eosinophilic Granulomatosis with Polyangiitis
    Location: Room 103AB
    Presenting Author: Núria Farran Centelles, -None- (she/her/hers) – IDIBAPS-FRCB
    Vasculitis
  • Tuesday, Nov 19th
    11:45 AM – 12:00 PM Eastern Time
    2692: Transcriptomic Profiling of Kidney Biopsies Implicates Th17 and IL-17 in ANCA-Associated Vasculitis
    Location: Room 103AB
    Presenting Author: Ivana Stojkic, MD – Nationwide
    Vasculitis
  • Tuesday, Nov 19th
    12:00 PM – 12:15 PM Eastern Time
    2693: Risk Factors for Relapse in ANCA-Associated Vasculitis Among Patients with Relapse After Induction of Remission with Rituximab
    Location: Room 103AB
    Presenting Author: Ellen Romich, MD – University of Pennsylvania
    Vasculitis
  • Tuesday, Nov 19th
    12:15 PM – 12:30 PM Eastern Time
    2694: Associations Between Immune Checkpoint Molecules and Nasal Microbiome in ANCA-associated Vasculitis
    Location: Room 103AB
    Presenting Author: Yoichi Nakayama, MD – Kyoto University
    Vasculitis